参考文献/References:
[1]杨浩,罗鹏程,付靖瑜,等.抗菌肽LL-37序列分析与结构研究[J].中华医院感染学杂志,2016(26):5079.[2]Fabisiak A,Murawska N,Fichna J.LL-37:Cathelicidin-related antimicrobial peptide with pleiotropic activity[J].Pharmacol Rep,2016,68(4):802-808.[3]Wehkamp J,Schauber J,Stange EF,et al.Defensins and cathelicidins in gastrointestinal infections[J].Current Opinion in Gastroenterology,2007,23(1):32-38.[4]徐喜媛,杨敬平,乌日娜.内皮祖细胞移植在脓毒症中的作用研究[J].临床肺科杂志,2015,19(3):510-512.[5]薄禄龙,卞金俊,邓小明.2016年脓毒症最新定义与诊断标准:回归本质重新出发[J].中华麻醉学杂志,2016,36(3):259-262.[6]Asher M.Sepsis researchers set sights on immunether-apeutic strategies[J].Nature Reviews Drug Discovery,2018,17(6):381-383.[7]Berkestedt I,Herwald H,Ljunggren L,et al.Elevated Plasma Levels of Antimicrobial Polypeptides in Patients with Severe Sepsis[J].Journal of Innate Immunity,2010,2(5):478-482.[8]郭巍娜,王春梅,霍方捷,等.人抗菌肽LL-37对老年脓毒症患者预后的评估价值[J].中华危重病急救医学,2018,30(11):1011-1016.[9]Wang G.Human Antimicrobial Peptides and Proteins[J].Pharmaceuticals,2014,7(5):545-594.[10]Qin X,Zhu G,Huang L,et al.LL-37 and its analog FF/CAP18 attenuate neutrophil migration in sepsis‐induced acute lung injury[J].J Cell Biochem,2019,120(4):4863-4871.[11]Wan M,van der Does AM,Tang X,et al.Antimicrobial peptide LL-37 promotes bacterial phagocytosis by human mac-rophages[J].J Leukoc Biol,2014,95(6):971-981.[12]Pinheiro da Silva F, Machado MC.The dual role of cathelicidins in systemic inflammation[J].Immunology Letters,2017(182):57-60.[13]Ahmed A,Siman-Tov G,Hall G,et al.Human Antimicrobial Peptides as Therapeutics for Viral Infections[J].Viruses,2019,11(8):E704.[14]Polesello V,Segat L,Crovella S,et al.Candida Infections and Human Defensins[J].Protein & Peptide Letters,2017,24(8):747.[15]Méndez-Samperio P.The human cathelicidin hCAP18/LL-37:A multifunctional peptide involved in mycobacterial infections[J].Peptides,2010,31(9):1791-1798.[16]Alexandre-Ramos DS,Silva-Carvalho AE,Lacerda MG,et al.LL-37 treatment on human peripheral blood mononuclear cells modulates immune response and promotes regulatory T-cells generation[J].Biomedicine&Pharmacotherapy,2018(108):1584-1590.[17]Scott MG,Davidson DJ,Gold MR,et al.The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses[J].J Immunol,2002,169(7):3883-3891.[18]Garcia-Orue I,Gainza G,Girbau C,et al.LL37 loaded nanostructured lipid carriers (NLC):A new strategy for the topical treatment of chronic wounds[J]. Eur J Pharm Biopharm,2016(108):310-316.[19]Ciornei CD,Tapper H,Bjartell A,et al.Human antimicrobial peptide LL-37 is present in atherosclerotic plaques and induces death of vascular smooth muscle cells: a laboratory study[J]. BMC Cardiovasc Disord,2006,6(1):49.[20]Chen X,Zou X,Qi G,et al.Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer[J].Cell Physiol Biochem,2018,47(3):1060-1073.
相似文献/References:
[1]李 谋,杨小琳,赵金礼.抗菌肽在炎症治疗方面的进展[J].医学信息,2018,31(06):42.[doi:10.3969/j.issn.1006-1959.2018.06.014]
LI Mou,YANG Xiao-lin,ZHAO Jin-li.Progress of Antimicrobial Peptides in the Treatment of Inflammation[J].Medical Information,2018,31(24):42.[doi:10.3969/j.issn.1006-1959.2018.06.014]
[2]谭 覃,徐 征,高尚谦,等.国内外感染伤口细菌生物膜处理方式的研究进展[J].医学信息,2018,31(22):43.[doi:10.3969/j.issn.1006-1959.2018.22.013]
TAN Tan,XU Zheng,GAO Shang-qian,et al.Advances in the Treatment of Bacterial Biofilm in Infected Wound at Home and Abroad[J].Medical Information,2018,31(24):43.[doi:10.3969/j.issn.1006-1959.2018.22.013]
[3]段训新,石玉英,黄 龙,等.反复上呼吸道感染患儿血清25羟维生素D3与LL-37及Ig水平的相关性[J].医学信息,2020,33(09):162.[doi:10.3969/j.issn.1006-1959.2020.09.054]
DUAN Xun-xin,SHI Yu-ying,HUANG Long,et al.Correlation of Serum Vitamin D3 with LL-37 and Ig Levels in Children with Repeated Upper Respiratory Tract Infections[J].Medical Information,2020,33(24):162.[doi:10.3969/j.issn.1006-1959.2020.09.054]